Beck Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,588
| Closed | -$1.55M | – | 150 |
|
|
2022
Q3 | $1.55M | Buy |
+19,588
| New | +$1.55M | 0.67% | 67 |
|
|
2019
Q3 | – | Sell |
-43,461
| Closed | -$3.81M | – | 116 |
|
|
2019
Q2 | $3.81M | Sell |
43,461
-1,576
| -3% | -$138K | 2.01% | 17 |
|
|
2019
Q1 | $4.08M | Buy |
+45,037
| New | +$4.08M | 1.95% | 16 |
|
|
2018
Q4 | – | Sell |
-75,539
| Closed | -$7.24M | – | 107 |
|
|
2018
Q3 | $7.24M | Sell |
75,539
-139
| -0.2% | -$13.3K | 3.11% | 5 |
|
|
2018
Q2 | $7.2M | Sell |
75,678
-2,189
| -3% | -$208K | 3.48% | 5 |
|
|
2018
Q1 | $6.83M | Buy |
77,867
+11,723
| +18% | +$1.03M | 3.14% | 8 |
|
|
2017
Q4 | $5.61M | Buy |
66,144
+2,245
| +4% | +$191K | 2.47% | 8 |
|
|
2017
Q3 | $5.53M | Buy |
63,899
+44,866
| +236% | +$3.88M | 2.64% | 9 |
|
|
2017
Q2 | $1.53M | Buy |
19,033
+14,103
| +286% | +$1.13M | 0.78% | 39 |
|
|
2017
Q1 | $352K | Buy |
+4,930
| New | +$352K | 0.19% | 80 |
|
|
2014
Q2 | – | Sell |
-20,505
| Closed | -$994K | – | 167 |
|
|
2014
Q1 | $994K | Sell |
20,505
-2,940
| -13% | -$143K | 0.76% | 44 |
|
|
2013
Q4 | $1.17M | Buy |
+23,445
| New | +$1.17M | 0.94% | 34 |
|